Syringomycin E inhibition of Saccharomyces cerevisiae: requirement for biosynthesis of sphingolipids with very-long-chain fatty acids and mannose- and phosphoinositol-containing head groups.
Syringomycin E is an antifungal cyclic lipodepsinonapeptide that inhibits the growth of Saccharomyces cerevisiae by interaction with the plasma membrane. A screen conducted to find the yeast genes necessary for its fungicidal action identified two novel syringomycin E response genes, SYR3 and SYR4. A syr3 mutant allele was complemented by ELO2 and ELO3. These genes encode enzymes that catalyze the elongation of sphingolipid very long chain fatty acids. Tetrad analysis showed that SYR3 was ELO2. Strains with deletions of SYR3/ELO2 and ELO3 were resistant to syringomycin E, and lipid analyses of both mutants revealed shortened fatty acid chains and lower levels of sphingolipids. SYR4 was identified by Tn5 inactivation of genomic library plasmids that complemented a syr4 mutant allele. SYR4 was found to be identical to IPT1, which encodes the terminal sphingolipid biosynthetic enzyme, mannosyl-diinositolphosphoryl-ceramide synthase. Deletion Deltasyr4/ipt1 strains were viable, were resistant to syringomycin E, did not produce mannosyl-diinositolphosphoryl-ceramide, and accumulated mannosyl-inositolphosphoryl-ceramide. Accumulation of mannosyl-inositolphosphoryl-ceramide was not responsible for resistance since a temperature-sensitive secretory pathway mutant (sec14-3(ts)) accumulated this sphingolipid and was sensitive to syringomycin E. Finally, Deltacsg1/sur1 and Deltacsg2 strains defective in the transfer of mannose to inositolphosphoryl-ceramide were resistant to syringomycin E. These findings show that syringomycin E growth inhibition of yeast is promoted by the production of sphingolipids with fully elongated fatty acid chains and the mannosyl and terminal phosphorylinositol moieties of the polar head group.
Stock
S D
SD
Department of Biology, Utah State University, Logan, Utah 84322-5305, USA.
Hama
H
H
Radding
J A
JA
Young
D A
DA
Takemoto
J Y
JY
D000123:Acetyltransferases; D000935:Antifungal Agents / Q000494:pharmacology*; D002135:Calcium-Binding Proteins / Q000235:genetics / Q000378:metabolism; D003001:Cloning, Molecular; D005227:Fatty Acids / Q000737:chemistry; D005656:Fungal Proteins / Q000235:genetics / Q000378:metabolism; D017353:Gene Deletion; D016695:Glycosyltransferases; D008358:Mannose / Q000737:chemistry; D008565:Membrane Proteins; D010456:Peptides, Cyclic / Q000494:pharmacology*; D010716:Phosphatidylinositols / Q000737:chemistry; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000235:genetics / Q000378:metabolism; D012097:Repressor Proteins / Q000235:genetics / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D029701:Saccharomyces cerevisiae Proteins; D013107:Sphingolipids / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000737:chemistry
D000935:Antifungal Agents; C086192:CSG2 protein, S cerevisiae; D002135:Calcium-Binding Proteins; D005227:Fatty Acids; D005656:Fungal Proteins; D008565:Membrane Proteins; D010456:Peptides, Cyclic; D010716:Phosphatidylinositols; D012097:Repressor Proteins; D029701:Saccharomyces cerevisiae Proteins; D013107:Sphingolipids; C105246:syringomycin E; D000123:Acetyltransferases; C107118:ELO2 protein, S cerevisiae; C107119:SUR4 protein, S cerevisiae; D016695:Glycosyltransferases; C092031:SUR1 protein, S cerevisiae; C109311:IPT1 protein, S cerevisiae; D017853:Phosphotransferases (Alcohol Group Acceptor); D008358:Mannose